Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

Neil R Poulter, Hans Wedel, Björn Dahlöf, Peter S Sever, D Gareth Beevers, Mark Caulfield, Sverre E Kjeldsen, Arni Kristinsson, Gordon T McInnes, Jesper Mehlsen, Markku Nieminen, Eoin O'Brien, Jan Ostergren, Stuart Pocock, ASCOT Investigators

Research output: Contribution to journalJournal articleResearchpeer-review

325 Citations (Scopus)

Abstract

Results of the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) show significantly lower rates of coronary and stroke events in individuals allocated an amlodipine-based combination drug regimen than in those allocated an atenolol-based combination drug regimen (HR 0.86 and 0.77, respectively). Our aim was to assess to what extent these differences were due to significant differences in blood pressures and in other variables noted after randomisation.
Original languageEnglish
JournalLancet
Volume366
Issue number9489
Pages (from-to)907-13
Number of pages7
ISSN0140-6736
DOIs
Publication statusPublished - Sep 2005

Cite this